A Novel Regimen of Transdermal Botulinum Toxin Delivery Using Fractional Microneedling Radiofrequency for Treatment of Erythema in Rosacea

Table 3

Investigator’s global assessment (IGA).

IGA	Visit 2 (n = 20)	Visit 3 (n = 20)	Visit 4 (n = 14)
0 (no improvement)	1 (5.00)	0 (0.00)	0 (0.00)
1 (0–10%)	1 (5.00)	1 (5.00)	1 (7.14)
2 (11–20%)	2 (10.00)	1 (5.00)	2 (14.29)
3 (21–30%)	4 (20.00)	2 (10.00)	3 (21.43)
4 (31–40%)	3 (15.00)	2 (10.00)	1 (7.14)
5 (41–50%)	3 (15.00)	3 (15.00)	1 (7.14)
6 (51–100%)	6 (30.00)	11 (55.00)	6 (42.86)

IGA, investigator’s global assessment. Values are presented as numbers (%).